| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8233740 | International Journal of Radiation Oncology*Biology*Physics | 2010 | 7 Pages |
Abstract
BT for both low-risk and selected intermediate-risk cancers achieves exceptional cure rates. Even with dose escalation, it will be difficult for EBRT to match the proven track record of BT seen over the past decade.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Tom M.D., Mira M.D., W. James M.D., Prostate Outcomes and Provincial Prostate Brachytherapy Program Prostate Outcomes and Provincial Prostate Brachytherapy Program,